Our partner is a leading biotechnology company focused on RNA interference (RNAi) therapeutics to target and silence disease-causing genes. With a robust pipeline of innovative treatments for rare genetic diseases and chronic conditions, the organization utilizes its proprietary technology platform to develop precision therapies that address significant unmet medical needs.

This critical hire provided expert medical oversight in the safety monitoring of clinical trials, ensuring the identification, assessment, and mitigation of safety risks. Led the development and implementation of safety monitoring plans, collaborated with clinical teams to evaluate adverse events, and ensured compliance with regulatory requirements, guiding trial decisions to protect patient safety and support successful study outcomes.